Discusses reasons for the failure of the biotechnology model of Germany. Encouragement of entrepreneurs in the life sciences to form businesses around biotechnology; Bias toward platform technologies over products; Emphasis on science and technology at the expense of medicines; Limitation of the role of the German government to the removal of barriers to the commercialization of innovation.